6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
58m ago	NIQ Insights: Asia Pacific Consumers Redefine Value Amid Ongoing Uncertainty
58m ago	Greenland Energy Announces Pricing of $70 Million Public Offering
1h ago	Tripadvisor Announces 2026 Travelers' Choice Awards: Best of the Best Things to Do, Recognizing the World's Most Loved Travel Experiences and Attractions
1h ago	DXC Introduces DXC OASIS to Reimagine Managed Services for the AI Era
1h ago	Enduro Metals Announces $5 Million LIFE Offering

About

Black Diamond Therapeutics Inc (NASDAQ:BDTX) — investor relations, events, news, and company updates on 6ix.

Latest News

Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Black Diamond Therapeutics Announces Preliminary Phase 2 Data for Silevertinib in 1L NSCLC and Plans for a Phase 2 Trial of Silevertinib in GBM

Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

Financials

Revenue

$70 M

Market Cap

$143.22 M

P/E Ratio

6.41

EPS

0.39

Community Chat

Ask AI